Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Eli Lilly is a pharma player, but it offers the growth of a tech stock thanks to its weight loss drugs portfolio. The weight ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Regeneron Pharmaceuticals, Inc. REGN is looking to make inroads in the lucrative obesity market. The company recently entered ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies ...

Breakingviews provides financial professionals with unique agenda-setting insight on the major financial news stories as they ...

While it’s now a top source of biopharmaceutical innovation, we believe China’s biotech sector is still in its early stages.